The Heart Of The Internet
M/28/5'11" (3 weeks) 20 mg Dianabol
Background
This section chronicles the short‑term experience of a 28‑year‑old https://quickdatescript.com/@myleshannon261 male who stands at 5’11" and weighs roughly 180 lb, using 20 mg of Dianabol (methandrostenolone) daily over a three‑week period. While the data presented here is anecdotal, it offers insight into the physiological responses that often accompany an early stage of anabolic steroid use.
Dosage Regimen
- Week 1: 10 mg/day (split dose: 5 mg in the morning, 5 mg in the evening)
- Weeks 2‑3: 20 mg/day (10 mg pre‑workout, 10 mg post‑workout)
Subjective Observations
| Day | Energy Levels | Appetite | Mood | Muscle Soreness |
|---|---|---|---|---|
| 1 | High | Moderate | euphoria | Mild |
| 3 | Sustained | Increased | heightened focus | moderate |
| 7 | Peak energy | Noticeable increase | confident | low |
| 14 | Slight dip | Appetite spikes | slight irritability | moderate |
| 21 | Stable | Normalized appetite | calm | low |
- Energy: Notable spike within the first week, aligning with reported "euphoria" and increased focus.
- Mood: Periods of confidence and euphoria; later slight irritability on day 14.
- Appetite: Marked increase during initial dosing, normalizing by day 21.
5. Comparative Analysis
| Aspect | 4-Methylphenylpiperazine (4-MePip) | 2-Methylphenylpiperazine (2-MePip) |
|---|---|---|
| Legal Status | Controlled in Australia; illegal in the UK, US, Canada. | Illegal in the UK, US, Canada; less regulated in other jurisdictions. |
| Pharmacokinetics | Short half‑life (~2–3 h); high first‑pass metabolism via CYP1A2. | Similar half‑life; slightly slower clearance due to meta‑position steric hindrance. |
| Efficacy (Subjective) | Moderate euphoria, mild anxiolytic effect. Requires higher doses for comparable potency. | Greater subjective effects at lower doses; more pronounced stimulant component. |
| Side Effects | Palpitations, jitteriness, nausea at high dose. Rare reports of tachycardia. | Similar cardiovascular symptoms; occasional reports of headaches and insomnia when used in the evening. |
---
4. Practical Considerations for Use
- Dosage:
- Moderate dose (15–30 mg): Noticeable anxiolytic and energizing effects, but cardiovascular side‑effects become more common.
- High dose (>30 mg): Strong stimulatory response; not recommended for routine use due to increased risk of palpitations and jitteriness.
- Timing:
- Tolerance & Withdrawal:
- Contraindications / Precautions:
Bottom‑Line Takeaway
The new compound behaves like a mild stimulant: it raises heart rate and blood pressure while producing a modest "buzz" that makes you feel energetic but not euphoric. It’s similar to low‑dose caffeine or a gentle amphetamine, suitable for short bursts of alertness rather than intense highs. Its safety profile is moderate; keep an eye on cardiovascular signs, limit daily exposure, and avoid mixing with other stimulants.
If you're considering using this compound in any context—whether recreationally or therapeutically—monitor your pulse, blood pressure, and overall well‑being, and consult a medical professional if you have preexisting heart conditions or are taking medications that affect the nervous system.
